Healthcare Industry News: Intravascular Temperature Management
News Release - July 2, 2007
Alsius Corporation Awarded National Marketing Agreement with AmerinetIRVINE, Calif.--(HSMN NewsFeed)--Alsius Corporation (OTCBB:ITHK ), a worldwide leader in advanced temperature management therapies, is pleased to announce the award of a national agreement with Amerinet, a market leading hospital group purchasing organization (GPO) serving more than 2,200 acute care facilities across the country. The agreement covers a three-year period effective July 1st through June 30, 2010, and involves collaboration across sales, marketing and customer service activities.
Through this agreement, Alsius is currently the only provider to Amerinet hospitals of Intravascular Temperature Management systems to administer patient cooling and warming therapy.
"This represents a milestone for Alsius as the technology of choice for facilities considering high performance temperature management systems to comply with ICU and surgical treatment guidelines," said William Worthen, CEO of Alsius. "We are excited to work closely with Amerinet to bring this innovative technology to its members and demonstrate how our Intravascular Temperature Management system manages patient cooling and warming more quickly and precisely than conventional methods."
To learn more, visit www.alsius.com or www.amerinet-gpo.com or contact your local Alsius representative.
Alsius, headquartered in Irvine, CA, is a commercial-stage medical device company that develops, manufactures and sells proprietary products to precisely control patient temperature in hospital critical care settings. Controlling body temperature, through cooling and warming, is becoming the standard of care for patients in select critical conditions and those undergoing a variety of surgical procedures. Alsius markets a comprehensive suite of catheter-based Intravascular Temperature Management products that address the need for effective, accurate, easy-to-use and cost-effective control of body temperature in critical care patients.
Alsius' products consist of the CoolGard and Thermogard systems and three families of single-use catheters. The systems are computer-controlled temperature regulation units that circulate cool or warm saline in a closed-loop through balloons that surround the catheters. Alsius' catheters are inserted into a major vein through a patient's neck or groin and achieve rapid and precise temperature management through contact with the patient's blood flow. Unlike conventional external temperature management products, such as cooling and warming blankets and ice packs, Alsius' intravascular products cool and warm the patient from the inside out, more effectively managing body temperature and allowing caregivers easier access to administer patient care. For more information, visit www.alsius.com.
About Amerinet Inc.
Through Total Spend Management Solutions, Amerinet strategically partners with health care providers to improve operating margins by creating efficiencies, reducing costs and identifying new revenue streams.
Supported by a team of clinical, data and supply chain experts, Amerinet offers a suite of tools, programs and services including a comprehensive and competitive portfolio that delivers practical solutions to address members' specific needs.
Based in St. Louis, Mo., with offices in Salt Lake City, Utah, Providence, R.I., and Warrendale, Pa., Amerinet serves more than 2,200 acute and non-acute health care providers nationwide. To learn more, visit www.amerinet-gpo.com.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to Alsius' future business performance and expectations. Forward-looking statements are typically identified by words or phrases such as "believe," "expect," "position," "achieve," and similar expressions. These statements are not guarantees of future performance and involve risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in the Company's filings with the Securities and Exchange Commission. The Company undertakes no duty to update any forward-looking statements made herein, except as required by law.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.